https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-payable-and-other-accrued-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accounts-receivable-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accretion-of-discount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-bonuses-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-bonuses-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-payroll-taxes-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-payroll-taxes-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-royalties-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-salaries-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-salaries-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-vacation-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accrued-vacation-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquired-cash-and-equivalents https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquired-contingent-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquired-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquired-intangible-assets-other-than-goodwill https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquired-intangibles https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-asset https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/amortization-of-value-of-business-acquired-voba https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cash-change https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/common-stock-shares-subscribed-but-unissued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/concentration-risk-percentage https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/contingent-consideration-classified-as-equity-fair-value-disclosure https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/contract-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/contract-with-customer-asset-net-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/convertible-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/convertible-debt-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/convertible-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cost-of-goods-sold https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/costs-and-expenses-related-party https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/customer-advances-and-deposits https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-convertible-beneficial-conversion-feature https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-convertible-effective-interest-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-face-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-increase-accrued-interest https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-interest-rate-effective-percentage-rate-range-minimum https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/debt-unamortized-discount-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-compensation-arrangement-with-individual-recorded-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-costs https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-costs-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-rent-credit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-revenue-revenue-recognized https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-state-taxes https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-liabilities-derivatives https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deposits-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deposits-assets-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/deposits-assets-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/derivative-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/dividends-declared https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/employee-related-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/equity-issuance-number-of-equity-securities-issued-for-noncash-considerations https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/fair-value-net-derivative-asset-liability-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-intangible-assets-purchase-accounting-adjustments https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-license-agreements-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/finite-lived-trademarks-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/form-d-corporate-securities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/form-d-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/form-d-stocks https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt-before-write-off-of-deferred-debt-issuance-cost https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/general-partners-contributed-capital https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/goodwill-acquired https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/goodwill-other-changes https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/gross-profit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/income-loss-from https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/income-loss-from-before-interest-expense-interest-income-income-taxes-extraordinary-items-noncontrolling-interests-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/income-loss-from-per-basic-and-diluted-share https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-accrued-salaries https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-deferred-charges https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-deferred-revenue-and-customer-advances-and-deposits https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-deposits https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-deposits-outstanding https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-notes-payable-related-parties https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-other-loans https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/incremental-common-shares-attributable-to-contingently-issuable-shares https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/insider-transactions-warrants https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/insider-transactions-warrants/purchases https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-and-debt-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-expense-on-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-expense-related-party https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-expense-subordinated-notes-and-debentures https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/interest-revenue-expense-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-finished-goods https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-lifo-reserve https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-raw-materials https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-raw-materials-and-supplies https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-raw-materials-and-supplies-net-of-reserves https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-work-in-process https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/investment-banking-advisory-brokerage-and-underwriting-fees-and-commissions https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/liabilities-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/licenses-revenue https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/line-of-credit https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/line-of-credit-facility-average-outstanding-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/line-of-credit-facility-capacity-available-for-trade-purchases https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/lines-of-credit-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/non-hedging-derivatives-gain-loss-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/notes-and-loans-payable-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/notes-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-liability https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-liability-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-income-2 https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-notes-payable-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-operating-income-expense-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/other-receivables-net-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/paid-in-capital-share-based-compensation-and-exercise-of-stock-options https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/paid-in-kind-interest https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/partners-capital-account-units-unitbased-compensation https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/payment-for-contingent-consideration-liability-investing-activities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/payments-for-proceeds-from-derivative-instrument-financing-activities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/payments-of-financing-costs https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/payments-to-employees https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-no-par-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/prepaid-expense-and-other-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/prepaid-insurance https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/prepaid-rent https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/prepaid-royalties https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-issuance-of-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-payments-for-long-term-loans-for-related-parties https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-short-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-short-term-debt-maturing-in-three-months-or-less https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-subordinated-short-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/professional-fees https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/property-plant-and-equipment-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/receivable-with-imputed-interest-net-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/repayments-of-short-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/repayments-of-subordinated-short-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/research-and-development-in-process https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/restricted-stock-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/retail-related-inventory https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/revenue-recognition-sales-returns-reserve-for-sales-returns https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/royalty-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/salaries-and-wages https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/sales-returns-and-allowances-goods https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/sales-revenue-net https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/settlement-assets-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/shares-outstanding-2 https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/shares-repurchased-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/short-term-bank-loans-and-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/short-term-non-bank-loans-and-notes-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-compensation-cost https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-for-stock-awards https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-shares-share-based-compensation-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/stockholders-equity-change https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-rate-reconciliation-minority-interest-income-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/taxes-payable-current https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/total-accounts-payable https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/total-long-term-debt https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/unamortized-debt-issuance-expense https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/valuation-allowances-and-reserves-adjustments https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/warrants-and-rights-outstanding https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/innovus-pharmaceuticals-inc/weighted-average-number-of-shares-outstanding-basic-and-diluted